News

MPN Landmark Survey

MPN News | July 20, 2017

MPN Landmark Survey funded by Incyte Corporation has been released

Read More

2017 Winners of the MPN Challenge Grant announced

MPN News | July 26, 2017

Five projects focused on MPN research

Read More

Digital Sherpa Workshops

MPN News | July 19, 2017

Join Patient Empowerment Network and MPN Research Foundation for Digital Sherpa Series

Read More

Follow up on the CALR mutation discovery

MPN News | July 7, 2017

Dr. Hasselbach describes CALR as an immunotherapy target in new Leukemia submission.

Read More

BREAKING NEWS

MPN News | June 26, 2017

AOP Orphan and PharmEssentia announces its latest clinical results for Ropeginterferon alfa-2b in Polycythemia Vera

Read More

Congratulations to Dr. Mesa on his Exciting Move

MPN News | June 13, 2017

Dr. Mesa move to UT Health Center

Read More

The MPN Challenge RFP is now open

MPN News | February 16, 2017

Apply for a grant now

Read More

The Mayo Clinic Is Seeking MPN Patients for Nutrition Survey

MPN News | 2/8/2017
Read More

Drs. Mullally and Mead describe in Blood the dominance of mutated cells.

MPN News | February 7, 2017
Read More

Remembering Robert Tollen, pioneer in MPN support.

MPN News | February 6, 2017
Read More

Pacritinib taken off FDA clinical hold.

MPN News | 1/5/2017

CTI BioPharma will start a new trial, PAC203 for Myelofibrosis

Read More

Phase 2 study combines Ruxolitinib and Decitabine for people with MPN

MPN News | December 21, 2016

Phase 2 study combines Ruxolitinib and Decitabine for people with MPN

Read More

Share your experience with Essential Thrombocythemia (ET) to help shape the future of treatment

MPN News | 12/12/2016

This research study is by QuintilesIMS (sponsored by Incyte Corporation) Background QuintilesIMS Global Services, a worldwide consulting firm, is conducting a research study to better understand the experience of ET patients. QuintilesIMS plans to interview patients who have been diagnosed with ET one‐on‐one over the phone. QuintilesIMS is looking for interested people to share what they have gone through since being diagnosed with ET. Purpose The overall purpose of the study is to learn which symptoms of ET are the most common, and how these symptoms typically affect the lives of patients like you who live with the disease. This understanding may help improve how the patient’s experience is accounted for in clinical trials that measure the effect of disease treatments. It also may help patients and their families by highlighting the consequences of the disease that most need greater attention, possibly leading to the development of new programs and support services.

Read More

MPN highlights from ASH's annual meeting

MPN News | December 12, 2016

MPN highlights from ASH's annual meeting

Read More

Katya Ravid makes discovery on using MRI to detect myelofibrosis

MPN News | November 21, 2016
Read More

Check our News - Archive for older news.

Get updates on MPN patients and research breakthroughs.

What are the latest developments in MPN Research?